SubjectWell secures $10m to expand patient recruitment marketplace

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/anyaberkut)
(Image: Getty/anyaberkut)

Related tags: SubjectWell, Patient recruitment

The clinical trials marketplace for patient recruitment, SubjectWell, has raised $10m in Series A funding and will further expand its services “into the rest of the English-speaking world,” says CEO.

The funding round was led by Windham Venture Partners, with participation from previous investors Healthy Ventures and Geekdom Fund.

SubjectWell CEO Ivor Clarke said the funds will enable the company to extend its offering into “the rest of the English-speaking world,” the UK, Europe, and South America. It also will grow its team to support demand and continue to expand its efforts to build clinical trial awareness.

The company previously conducted a survey​​ to detail consumer perceptions of clinical trials. Of the respondents, half had never even heard of clinical trials – and 96% had never participated in a clinical trial. Additionally, very few (31%) felt “confident or very confident” that they would know how to get information about clinical trials.

“We’re offering a risk-free way for sponsors to meet their enrollment goals with an outreach message that is unique and complementary to typical study-specific efforts,”​ said Clarke, speaking to what is driving the company’s growth.

“We are fervent in our belief that charging per-randomization is the right model for the industry,”​ he added. “Performance-based pricing is the norm in other industries, and it is central to our efforts to build a single marketplace that can match patients to any available clinical trial.”

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars